Ligand Pharmaceuticals Company Insiders

Ligand Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of 0.013 % which means that it generated a profit of $0.013 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.06 %, meaning that it created $0.06 on every $100 dollars invested by stockholders. Ligand Pharmaceuticals' management efficiency ratios could be used to measure how well Ligand Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. At present, Ligand Pharmaceuticals' Return On Capital Employed is projected to increase slightly based on the last few years of reporting. The current year's Return On Assets is expected to grow to 0.07, whereas Return On Equity is forecasted to decline to 0.07. At present, Ligand Pharmaceuticals' Non Currrent Assets Other are projected to decrease significantly based on the last few years of reporting. The current year's Intangible Assets is expected to grow to about 385.2 M, whereas Other Current Assets are forecasted to decline to about 3.6 M. As of November 29, 2024, Common Stock Shares Outstanding is expected to decline to about 16.2 M. The current year's Net Loss is expected to grow to about (36.4 M)

Ligand Pharmaceuticals Workforce Comparison

The company has Profit Margin (PM) of 0.3 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.21 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.21.

Ligand Pharmaceuticals Insider Trading History

Ligand Pharmaceuticals Notable Stakeholders

The success or failure of an entity such as Ligand Pharmaceuticals often depends on how effective the management is. Ligand Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Ligand management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Ligand management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of Ligand Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ligand Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Ligand Pharmaceuticals' management manipulating its earnings.

When running Ligand Pharmaceuticals' price analysis, check to measure Ligand Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ligand Pharmaceuticals is operating at the current time. Most of Ligand Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ligand Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ligand Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ligand Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.